Stellanin-PEG, 3% ointment 20 g

The mechanism of the drug’s pharmacological activity lies in the antibacterial action of 1.3-diethylbenzimidazolium.

The active iodine contained in 1.3-diethylbenzimidazolium triiodide inactivates bacterial wall proteins and enzyme proteins of bacteria, thus having a bactericidal effect on microorganisms. The pronounced antimicrobial action of the drug prevents infection of wounds.

Along with antibacterial and anti-inflammatory effects the ointment has a high osmotic potential which is particularly important in the treatment of septic wounds as it promotes the evacuation of purulent discharge from the wound defect.

Pharmacokinetics

There is no systemic absorption of the active ingredient even in damaged skin; however, therapeutic concentrations of the drug are present in the wound.

Indications

Treatment of acute purulent processes (wounds) of the skin and soft tissues (boils, carbuncles, hydroadenitis, phlegmon, abscesses);
additional treatment of purulent complications of postoperative wounds (after excision, coagulation, episiotomy, for the treatment of skin cracks, wounds and sutures);
thermal damage to the skin and soft tissues of degrees I-III, complicated by an infectious process;
trophic ulcers, bedsores complicated by an infectious process.
abrasions, cuts, scratches, cracks, scratches.

Pharmacological effect

The mechanism of pharmacological activity of the drug is the antibacterial effect of 1.3-diethylbenzimidazolium.

Active iodine, which is part of 1.3-diethylbenzimidazolium triiodide, inactivates bacterial wall proteins and bacterial enzyme proteins, thereby exerting a bactericidal effect on microorganisms. The pronounced antimicrobial effect of the drug prevents wound infection.

Along with antibacterial and anti-inflammatory effects, the ointment has a high osmotic potential, which is especially important in the treatment of purulent wounds, because promotes the evacuation of purulent discharge from the wound defect.

Pharmacokinetics

Systemic absorption of the active substance is absent even with damaged skin, however, therapeutic concentrations of the drug are present in the wound.

Special instructions

Avoid getting the ointment in your eyes.

If the drug gets into your eyes, rinse with warm water.

Active ingredient

Diethylbenzimidazolium triiodide

Composition

100 g of ointment for external use contains:

Active substance:

1,3-diethylbenzimidazolium triiodide – 3.0 g;

Excipients:

povidone (low molecular weight polyvinylpyrrolidone),

dimexide,

polyethylene oxide 1500 (polyethylene glycol 1500),

polyethylene oxide 400 (polyethylene glycol 400).

Pregnancy

It is forbidden to take the drug Stellanin-PEG in the first trimester of pregnancy.

Take with caution in the II and III trimesters of pregnancy and during lactation.

Contraindications

Hypersensitivity to the components of the drug Stellanin-PEG,
thyrotoxicosis,
thyroid adenoma,
severe renal failure,
simultaneous therapy with radioactive iodine,
children under 18 years old,
I trimester of pregnancy.

With caution: chronic renal failure, II and III trimesters of pregnancy, lactation period.

Side Effects

In rare cases, allergic skin reactions (itching, skin hyperemia) are possible, and if they occur, you should stop using the drug.

Interaction

Stellanin-PEG should not be used in combination with other antiseptics containing mercury, oxidizing agents, alkalis and cationic surfactants.

An alkaline or acidic environment, the presence of fat, pus, and blood weaken the antiseptic activity.

Overdose

Cases of overdose have not been described.

If the drug is accidentally taken orally, nausea and vomiting may occur.

It is necessary to rinse the stomach and consult a doctor; if necessary, carry out symptomatic treatment.

Storage conditions

The drug should be stored in a dry place, protected from light, at a temperature of 0-25 ° C.

Shelf life

2 years.

Manufacturer

Pharmpreparat, Russia